Avdoralimab (Anti-Complement C5aR1)Avdoralimab (Anti-Complement C5aR1)
Move your mouse over image or click to enlarge

Avdoralimab (Anti-Complement C5aR1)

Avdoralimab (Anti-Complement C5aR1) is a fully human IgGκ monoclonal antibody targeting the complement C5a receptor 1 (C5aR1), that prevents its binding to C5a. Avdoralimab can be used for complement-driven inflammatory diseases and solid tumours research. MW: 145.5 KD.
Cat# Size Price Qty Buy
A2536-1mg*25 1mg*25
£4,152.00
A2536-1mg*5 1mg*5
£1,384.00
A2536-1mg 1mg
£441.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2536

Related Documents